Novartis set to buy Avidity Biosciences for more than $10bn ○
found
a story from Financial Times ✅ › Financial Times
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Deal would be biggest acquisition under chief executive Vas Narasimhan